Patient survival (5-year) within grade III and IV groups was 43.3% in the low-PHGDH expression group compared with 18.5% in the high-PHGDH expression group (p < 0.001), underscoring PHGDH as a prognostic marker for glioma [45]. The gene discussed is PHGDH; the disease is glioma.